Format

Send to

Choose Destination
J Reprod Med. 2001 Feb;46(2):83-6.

Betamethasone alteration of the one-hour glucose challenge test in pregnancy.

Author information

1
Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Texas Medical School at Houston, 6431 Fannin, Suite 3.604, Houston, TX 77030, USA. joan.m.mastrobattista@uth.tmc.edu

Abstract

OBJECTIVE:

To determine if betamethasone administration alters the one-hour (50-g) glucose challenge test (GCT) and, if so, to determine the duration of this effect.

STUDY DESIGN:

Pregnant women with singleton gestations eligible to receive antenatal betamethasone (24-34 weeks) with no evidence of infection, diabetes mellitus, hepatic or pancreatic disease, betamimetic therapy or prolonged steroid use were invited to participate. Betamethasone (12 mg) was administered intramuscularly upon admission and repeated in 24 hours. After an 8-hour fast, a 50-g GCT was administered 24 hours (day 1) and 72 hours (day 3) after the second betamethasone injection. Plasma glucose samples were drawn one hour after the glucose challenge. Statistical analysis utilized the McNemar exact test.

RESULTS:

Seven patients, all with normal GCTs 7-10 days outside the study period, were enrolled. Six had abnormal GCT results on day 1 (P = .03). Three had abnormal results on day 3.

CONCLUSION:

Betamethasone administration results in abnormal one-hour GCTs in pregnant women.

PMID:
11255820
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center